Clinical Trial Update: A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

View source ↗

Summary

A clinical trial update indicating recruitment is ongoing for participants with Beta-Thalassemia treated with Betibeglogene Autotemcel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Betibeglogene Autotemcel

Snippet

Sponsor: Genetix Biotherapeutics Inc. | Conditions: Beta-Thalassemia | Status: RECRUITING